Kanes Stephen - Insider Stock Trading - OpenInsider

CIK: 1612859 - Address: C/o Sage Therapeutics, Inc., 215 First Street, Cambridge, MA 02142

17 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	1	-1	-6	6	27	40	179	41
P	%wins				0	0	100	100	100	100	67
S	%ret	1	1	8	1	1	-1	18	-2	-26	-2
S	%wins				50	50	50	38	50	86	54

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/5/19 16:33	9/4/19	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	3	0.4500	0	6	262	8	D
2/8/19 17:08	2/8/19	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S	-3,442	150.00	0	-23	-96	1	D
1/12/18 16:07	1/10/18	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-7,796	177.18	0	-44	-66	23	D
1/12/18 16:07	1/12/18	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	9	0.4500	0	20	678	23	D
4/21/16 13:53	4/19/16	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-798	38.00	20	-21	-31	47	D		-39	-19	-2	15	18	10	3	4	-3	-20	14	9
4/21/16 13:53	4/20/16	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	9	0.4500	20	21	81	47	D		-39	-19	-2	15	18	10	3	4	-3	-20	14	9
9/29/15 18:24	9/28/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	9	0.4500	20	21	81	47	D		44	-16	-37	-31	-23	-27	-17	4	11	20	42	-22	14
9/29/15 18:24	9/28/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-279	46.42	20	-6	-11	47	D		44	-16	-37	-31	-23	-27	-17	4	11	20	42	-22	14
9/1/15 15:59	8/31/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S	-637	53.12	25	-12	-27	32	D		87	23	-27	-28	-15	-1	7	-4	4	-22	-11	-36	-30
7/29/15 13:57	7/27/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	1	0.4500	21	2	5	44	D		181	82	35	-4	9	-5	-3	-5	-6	-31	-37	-52	-38
7/29/15 13:57	7/27/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-347	70.24	21	-5	-10	44	D		181	82	35	-4	9	-5	-3	-5	-6	-31	-37	-52	-38
6/25/15 12:29	6/24/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	M.d	3	0.4500	33	6	15	47	D			82	65	29	-6	-5	5	-2	-6	-2	-30	-20	-58
6/25/15 12:29	6/24/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-444	74.06	33	-6	-11	47	D			82	65	29	-6	-5	5	-2	-6	-2	-30	-20	-58
3/27/15 11:22	3/25/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S	-278	51.49	11	-5	-10	47	D			54	17	11	6	-3	-12	11	3	20	59	16	-32
2/27/15 16:04	2/25/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S	-252	42.05	8	-6	-10	52	D			44	9	7	10	4	0	1	3	17	69	16	-29
1/27/15 16:15	1/26/15	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	S.d	-224	37.29	5	-6	-9	58	D			53	14	5	1	1	5	0	0	7	36	72	-6
7/23/14 18:51	7/23/14	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Kanes Stephen	MA	O	Chief Me	P	54	18.00	33	3	New	3	D									-1	-6	6	27	40	179

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact